UK tribunal's hydrocortisone case findings weren’t flawed, regulator says
By Simon Zekaria ( June 24, 2026, 15:32 GMT | Insight) -- The UK competition tribunal didn’t err when it upheld key findings from the competition watchdog over antitrust breaches in relation to the supply of hydrocortisone tablets, the regulator told UK appeal judges Wednesday. At the Court of Appeal, drugmakers sanctioned over their pricing behaviors are challenging specific court rulings.The UK competition tribunal didn’t err when it upheld key findings from the competition watchdog over antitrust breaches in relation to the supply of hydrocortisone tablets, the regulator told UK appeal judges Wednesday....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.